KEWAUNEE SCIENTIFIC CORP /DE/
For the period ended Apr 30, 2025. Filed Jul 2, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jul 2, 2025
KEQU$33.61-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets—April 30, 202 and
CONSOLIDATED BALANCE SHEETS
| April 30 | Kewaunee Scientific Corporation | |
|---|---|---|
| $ and shares in thousands, except per share amounts | 2025 | 2024 |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $14,942 | $23,267 |
| Restricted cash | 2,222 | 2,671 |
| Receivables, less allowance: $530 (2025); $588 (2024) | 62,384 | 45,064 |
| Inventories | 32,849 | 20,679 |
| Prepaid expenses and other current assets | 5,966 | 5,136 |
| Total Current Assets | 118,363 | 96,817 |
| Property, plant and equipment, net | 23,174 | 17,649 |
| Right of use assets | 12,965 | 7,454 |
| Deferred income taxes | 3,994 | 7,401 |
| Intangible assets, net | 17,831 | — |
| Goodwill | 12,487 | — |
| Other assets | 5,840 | 5,445 |
| Total Assets | $194,654 | $134,766 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current Liabilities | ||
| Short-term borrowings | $986 | $3,099 |
| Current portion of financing liability | 788 | 713 |
| Current portion of term loan | 2,903 | — |
| Current portion of financing lease liabilities | 96 | 111 |
| Current portion of operating lease liabilities | 3,275 | 2,123 |
| Accounts payable | 27,033 | 23,262 |
| Employee compensation and amounts withheld | 9,209 | 6,041 |
| Deferred revenue | 6,073 | 4,374 |
| Other accrued expenses | 3,349 | 1,057 |
| Total Current Liabilities | 53,712 | 40,780 |
| Long-term portion of financing liability | 26,632 | 27,420 |
| Long-term portion of seller note | 23,537 | — |
| Long-term portion of term loan | 10,412 | — |
| Long-term portion of financing lease liabilities | 149 | 235 |
| Long-term portion of operating lease liabilities | 8,797 | 5,434 |
| Accrued pension and deferred compensation costs | 3,708 | 3,008 |
| Deferred income taxes | 1,098 | 1,218 |
| Other non-current liabilities | 364 | 462 |
| Total Liabilities | 128,409 | 78,557 |
| Commitments and Contingencies (Note 12) | ||
| Stockholders' Equity | ||
| Common stock, $2.50 par value, Authorized—5,000 shares; | ||
| Issued— 2,941 shares (2025); 2,909 shares (2024) | ||
| Outstanding— 2,839 shares (2025); 2,839 shares (2024) | 7,353 | 7,273 |
| Additional paid-in capital | 5,635 | 5,406 |
| Retained earnings | 58,919 | 47,514 |
| Accumulated other comprehensive loss | (3,803) | (3,382) |
| Common stock in treasury, at cost: 103 shares (2025); 70 shares (2024) | (3,647) | (2,051) |
| Total Kewaunee Scientific Corporation Stockholders' Equity | 64,457 | 54,760 |
| Non-controlling interest | 1,788 | 1,449 |
| Total Stockholders' Equity | 66,245 | 56,209 |
| Total Liabilities and Stockholders' Equity | $194,654 | $134,766 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.